Monoamine oxidase inhibitors (MAOIs) are a class of drugs used primarily as antidepressants. They work by inhibiting the activity of the enzyme monoamine oxidase, which breaks down neurotransmitters such as serotonin, dopamine, and norepinephrine. This leads to an increase in the levels of these neurotransmitters in the brain, which can help to alleviate the symptoms of depression.
Get A Report Copy of this Market: https://wemarketresearch.com/r....eports/monoamine-oxi